TABLE 2

ED50 values and 95% confidence limits (CL) for rate-decreasing effects of GHB, baclofen, and diazepam alone, and following a dose of antagonist


Test Compound

Dose (mg/kg) Antagonist

n

ED50

95% CL
GHB 0 8 218.6* 190.2 251.2
CGP 35348 (56) 8 259.0 193.3 347.1
CGP 35348 (100) 5 188.0 127.5 277.2
CGP 35348 (178) 8 302.8 240.8 380.8
GHB NCS-382 (10) 6 195.4 146.2 261.1
NCS-382 (32) 6 188.0 136.4 259.2
GHB Flumazenil (5.6) 6 234.5 170.1 323.2
Baclofen 0 8 2.2 1.9 2.6
CGP 35348 (56) 7 3.5a 3.1 3.8
CGP 35348 (100) 6 3.8a 2.4 6.0
CGP 35348 (178) 7 4.5a 3.9 5.1
Baclofen NCS-382 (10) 6 2.4 1.9 3.0
NCS-382 (32) 7 3.0 2.5 3.6
NCS-382 (56) 4 2.8 1.1 6.8
Diazepam 0 8 2.4 1.6 3.8
Flumazenil (1.0) 6 2.9 1.4 6.4
Flumazenil (3.2) 4 5.4b 3.9 7.4
Flumazenil (5.6) 8 8.8b 4.5 17.2
Diazepam NCS-382 (10) 6 0.6b 0.2 1.6
NCS-382 (32) 7 1.7 0.9 3.3

NCS-382 (56)
6
2.0
0.9
4.8
  • * Individual ED50 values were averaged across four determinations; individual average ED50 values were used to calculate the reported ED50 and 95% CL values

  • Individual ED50 values were averaged across 2 determinations; individual average ED50 values were used to calculate the reported ED50 and 95% CL values

  • a Significant difference (α = 0.05) from control baclofen ED50 value (Dunnett's test)

  • b Significant difference (α = 0.05) from control diazepam ED50 value (Dunnett's test)